Get the SPI Wire

CALCIMEDICA, INC.

NASDAQ:CALC
Annual Meeting

of Shareholders

MEETING DATE

08/19/2026
DEF 14A FILED
07/23/2026
PUBLISHED
07/23/2026 8:06 pm
TIME TO PUBLISH
07/25/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CALC · CUSIP 38942Q202 · CLASS common stock · CIK 0001534133

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

8
FOR
0
AGAINST
0
WITHHOLD
8
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Election of Class III Directors
board
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board nominated two Class III directors for three-year terms.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Ratification of Appointment of Independent Registered Public Accounting Firm
auditor
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee approved Baker Tilly and disclosed no disagreements with current or predecessor auditors.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To Approve an Amendment to the CalciMedica, Inc. Amended 2023 Equity Incentive Plan
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The amendment would add 7,500,000 shares and modify annual automatic share reserve increases.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
Advisory Vote on Executive Compensation
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states the vote is advisory and the Board will consider the results.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation
compensation
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board determined that a say-on-pay vote every year is most appropriate.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
6
Reverse Stock Split and Authorized Shares Reduction
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The Board states the proposal is intended to regain compliance with Nasdaq minimum bid price requirements.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
7
Nasdaq Listing Rule 5635(d) Warrant Issuance Proposal
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states failure to approve may materially adversely affect capital raising and operations.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
8
Nasdaq Listing Rule 5635(c) Director and Officer Issuance Proposal
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states non-approval would reduce potential cash exercise proceeds by up to $3,030,562.87.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

a93cdb05163d30f8b53a365f5fdb1e1808787e653bfe872494d02143d47f5f18

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates